Toshiki Ochi

Princess Margaret Cancer Centre, University Health Network

Affiliated withUniversity Health Network University Health Network

Research Area

Biography

Toshiki Ochi has not added Biography.
If you are Toshiki Ochi and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2016

Other Publications

Article	Year
Identification of an epitope derived from CML66, a novel tumor-associated antigen expressed broadly in human leukemia, recognized by human leukocyte antigen-A*2402-restricted cytotoxic T lym... Cancer science\| PubMed ID: 18422754	2008
Aurora-A kinase: a novel target of cellular immunotherapy for leukemia. Blood\| PubMed ID: 18820130	2009
Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome. American journal of hematology\| PubMed ID: 19338044	2009
Identification of a novel epitope derived from CML66 that is recognized by anti-leukaemia cytotoxic T lymphocytes. British journal of haematology\| PubMed ID: 19388930	2009
HBZ is an immunogenic protein, but not a target antigen for human T-cell leukemia virus type 1-specific cytotoxic T lymphocytes. The Journal of general virology\| PubMed ID: 19423550	2009
Aurora-A kinase: a novel target both for cellular immunotherapy and molecular target therapy against human leukemia. Expert opinion on therapeutic targets\| PubMed ID: 19821797	2009
Germ cell tumor concomitant with acquired immune deficiency syndrome. Internal medicine (Tokyo, Japan)\| PubMed ID: 20009406	2009
Application of adoptive T-cell therapy using tumor antigen-specific T-cell receptor gene transfer for the treatment of human leukemia. Journal of biomedicine & biotechnology\| PubMed ID: 20454585	2010
Human herpesvirus 6 infection impairs Toll-like receptor signaling. Virology journal\| PubMed ID: 20459723	2010
Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2r gamma(null) humanized mice. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 20615947	2010
Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes. PloS one\| PubMed ID: 21152410	2010
Activation of T-cell receptor signaling in peripheral T-cell lymphoma cells plays an important role in the development of lymphoma-associated hemophagocytosis. International journal of hematology\| PubMed ID: 21229399	2011
Adoptive T-cell immunotherapy using T-cell receptor gene transfer: aiming at a cure for cancer. Immunotherapy\| PubMed ID: 21322752	2011
Requisite considerations for successful adoptive immunotherapy with engineered T-lymphocytes using tumor antigen-specific T-cell receptor gene transfer. Expert opinion on biological therapy\| PubMed ID: 21413911	2011
Gemcitabine enhances Wilms' tumor gene WT1 expression and sensitizes human pancreatic cancer cells with WT1-specific T-cell-mediated antitumor immune response. Cancer immunology, immunotherapy : CII\| PubMed ID: 21607557	2011
Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. Blood\| PubMed ID: 21673345	2011
Aurora kinase A-specific T-cell receptor gene transfer redirects T lymphocytes to display effective antileukemia reactivity. Blood\| PubMed ID: 22025529	2012
Co-introduced functional CCR2 potentiates in vivo anti-lung cancer functionality mediated by T cells double gene-modified to express WT1-specific T-cell receptor. PloS one\| PubMed ID: 23441216	2013
Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia. Blood\| PubMed ID: 23641014	2013
Adoptive transfer of genetically engineered WT1-specific cytotoxic T lymphocytes does not induce renal injury. Journal of hematology & oncology\| PubMed ID: 24393438	2014
Specific roles of each TCR hemichain in generating functional chain-centric TCR. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 25710913	2015
Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy. Cancer immunology research\| PubMed ID: 25943533	2015
Induction of WT1-specific human CD8+ T cells from human HSCs in HLA class I Tg NOD/SCID/IL2rgKO mice. Blood\| PubMed ID: 26702062	2016
CDR3β sequence motifs regulate autoreactivity of human invariant NKT cell receptors. Journal of autoimmunity\| PubMed ID: 26748722	2016
CD4(+) and CD8(+) TCRβ repertoires possess different potentials to generate extraordinarily high-avidity T cells. Scientific reports\| PubMed ID: 27030642	2016
Mouse and Human CD1d-Self-Lipid Complexes Are Recognized Differently by Murine Invariant Natural Killer T Cell Receptors. PloS one\| PubMed ID: 27213277	2016
BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models. The Journal of clinical investigation\| PubMed ID: 27548527	2016